Coronavirus Update - 24th June 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual.

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The latest news from Arcinova

November 24, 2016

Arcinova Q4 Newsletter 2016

The Q4 newsletter, featuring important updates including the progression of our API development capabilities and the installation of the new GC-MS instrument and installation of the 5 Litre and 20
July 27, 2016

Arcinova Q3 Newsletter 2016

We are proud to present our first quarterly newsletter, with important updates including the progression of our API development capabilities and the addition of GC-MS to broaden the scope of our o
June 1, 2016

C&EN Article

Following a visit to Alnwick and a tour of Arcinova's facilities, Alex Scott wrote an article in the May 30th 2016 edition of C&EN, outlining the acquisition story and the growth prospects for
April 14, 2016

Welcome to Mark Chadwick

Mark joins Arcinova from AIM-listed Physiomics plc, where he was CEO for 5 years. Mark’s previous roles include CEO of Envirogene and VP of Business Development at Excelsyn. Before joining Exc
March 16, 2016

Evening Chronicle Article

Last month the Evening Chronicle featured an article regarding the formation of ARC Trinova & Arcinova. The article explains that the formation of ARC Trinova, trading as Arcinova, has saved f
January 22, 2016

New company, new website

Arcinova is set to make some exciting changes to the existing business and site. Not only will there be restructuring and physical changes but we've also commissioned this brand new website to let
January 22, 2016

Press Release

ARC Trinova is acquiring site in Alnwick to form International Contract Research and Development Business. Arc Trinova, a new company formed by Ian Shott and Paul Ryan, owners of Shott Tri

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.